Biofrontera refiles supplemental new drug application for Ameluz topical gel to FDA for actinic keratoses

Biofrontera refiled its supplemental new drug application to the FDA to expand Ameluz red light photodynamic therapy to treat actinic keratoses on the full body.

Detected & updated continuously · Source: Nebula